Demand for animal health chemicals in the US will reach $7.8 billion in 2006. Gains will be driven by the continuing threat of animal disease, ongoing food safety concerns and growth in the pet population. Diagnostic chemicals and vaccines will be the fastest growing products, while feed manufacturers, farms and households lead market gains.
This study analyzes the $6.4 billion US animal health chemical industry. It presents historical data for 1992, 1996 and 2001 and forecasts to 2006 and 2011 by product (e.g., nutritional chemicals, parasiticides, vaccines, therapeutic antibiotics, systemic agents, growth promotants, diagnostic chemicals, disinfectants and antifungal agents); by end user and by animal class (e.g., livestock and poultry, companion animals).
The study also examines the market environment, details industry structure, presents market share data and profiles 30 selected industry competitors including Merial, Pfizer, Wyeth, Eli Lilly, Schering-Plough, and Roche.
